Genentech AMD Research Fellowships
As many as 11 million people in the United States have some form of age-related macular degeneration. This number is expected to double to nearly 22 million by 2050. The impact of age-related macular degeneration on the global aging population is enormous as people are deprived of their economic livelihoods and independence.
The Genentech Age-related Macular Degeneration (AMD) Research Fellowships support two grants:
- basic research in the understanding of AMD and
- translational AMD research focusing on therapeutics (not yet in clinical trials)
Established in 2011, the Genentech AMD Research Fellowships concluded in 2019 and will not be accepting further applications.
2019 Genentech AMD Research Fellowship recipients
Genentech AMD Research Fellowship (Basic)
Susana da Silva, PhD
Establishment of a foveated human 3D retinal organoid system to model AMD.
Genentech AMD Research Fellowship (Translational)
Dimitra Skondra, MD, PhD
Common antidiabetic drug metformin prevents AMD by reshaping the gut microbiome.